School of Cancer Sciences

Dr Kendle Maslowski

  • Senior Lecturer (CRUK Scotland Institute)

Research interests

Research groups

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021
Number of items: 5.

2024

Copland, A. et al. (2024) Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity. EMBO Molecular Medicine, 16(12), pp. 3057-3088. (doi: 10.1038/s44321-024-00159-2) (PMID:39558103) (PMCID:PMC11628626)

2023

Fisch, D. et al. (2023) PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection. Science, 382(6666), eadg2253. (doi: 10.1126/science.adg2253) (PMID:37797010) (PMCID:PMC7615196)

2022

Bombaci, G. et al. (2022) LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity. Life Science Alliance, 5(6), e202101226. (doi: 10.26508/lsa.202101226) (PMID:35256513) (PMCID:PMC8922048)

2021

Mackie, Gillian M., Copland, Alastair, Takahashi, Masumi, Nakanishi, Yumiko, Everard, Isabel, Kato, Tamotsu, Oda, Hirotsugu, Kanaya, Takashi, Ohno, Hiroshi and Maslowski, Kendle M. ORCID logoORCID: https://orcid.org/0000-0003-1995-5424 (2021) Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape. JCI Insight, 6(23), e139900. (doi: 10.1172/jci.insight.139900) (PMID:34710062) (PMCID:PMC8675204)

Elliot, Thomas A.E., Jennings, Emma K., Lecky, David A.J., Natash, Natasha, Flores-Langarica, Adriana, Copland, Alastair, Maslowski, Kendle M. ORCID logoORCID: https://orcid.org/0000-0003-1995-5424, Wraith, David C. and Bending, David (2021) Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength. Immunity, 54(11), 2481-2496.e6. (doi: 10.1016/j.immuni.2021.08.020) (PMID:34534438) (PMCID:PMC8585507)

This list was generated on Sat Apr 4 14:26:40 2026 BST.
Jump to: Articles
Number of items: 5.

Articles

Copland, A. et al. (2024) Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity. EMBO Molecular Medicine, 16(12), pp. 3057-3088. (doi: 10.1038/s44321-024-00159-2) (PMID:39558103) (PMCID:PMC11628626)

Fisch, D. et al. (2023) PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection. Science, 382(6666), eadg2253. (doi: 10.1126/science.adg2253) (PMID:37797010) (PMCID:PMC7615196)

Bombaci, G. et al. (2022) LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity. Life Science Alliance, 5(6), e202101226. (doi: 10.26508/lsa.202101226) (PMID:35256513) (PMCID:PMC8922048)

Mackie, Gillian M., Copland, Alastair, Takahashi, Masumi, Nakanishi, Yumiko, Everard, Isabel, Kato, Tamotsu, Oda, Hirotsugu, Kanaya, Takashi, Ohno, Hiroshi and Maslowski, Kendle M. ORCID logoORCID: https://orcid.org/0000-0003-1995-5424 (2021) Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape. JCI Insight, 6(23), e139900. (doi: 10.1172/jci.insight.139900) (PMID:34710062) (PMCID:PMC8675204)

Elliot, Thomas A.E., Jennings, Emma K., Lecky, David A.J., Natash, Natasha, Flores-Langarica, Adriana, Copland, Alastair, Maslowski, Kendle M. ORCID logoORCID: https://orcid.org/0000-0003-1995-5424, Wraith, David C. and Bending, David (2021) Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength. Immunity, 54(11), 2481-2496.e6. (doi: 10.1016/j.immuni.2021.08.020) (PMID:34534438) (PMCID:PMC8585507)

This list was generated on Sat Apr 4 14:26:40 2026 BST.